Companies: 10,795·Total market cap: $144.5T
Myovant Sciences Ltd.

Myovant Sciences Ltd.

MYOVNYSEHealthcare
$26.98
$-0.01(-0.04%)
Market Cap$2.6B
P/E Ratio
52W High$27.06
52W Low$7.67

Myovant Sciences Ltd.(MYOV)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MYOV · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2022-032021-032020-032019-032018-03
Revenue
Revenue$0.23B$0.06B$0.00B$0.00B$0.00B
Cost of Revenue$0.05B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.18B$0.06B$0.00B$0.00B$0.00B
Gross Margin %(computed)77.68%96.69%
Operating Expenses
R&D Expenses$0.11B$0.14B$0.19B$0.22B$0.12B
G&A Expenses$0.00B$0.00B$0.08B$0.04B$0.02B
Total Operating Expenses$0.37B$0.32B$0.27B$0.26B$0.14B
Operating Income($0.19B)($0.26B)($0.27B)($0.26B)($0.14B)
Operating Margin %(computed)-81.11%-439.64%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.00B
Income Before Tax($0.20B)($0.25B)($0.29B)($0.27B)($0.14B)
Income Tax Expense$0.01B$0.00B$0.00B$0.00B$0.00B
Net Income($0.21B)($0.26B)($0.29B)($0.27B)($0.14B)
Net Margin %(computed)-89.18%-430.12%
Per Share & EBITDA
EPS (Basic)$-2.22$-2.83$-3.37$-4.09$-2.41
Wtd Avg Shares0.09B0.09B0.09B0.07B0.06B
EBITDA($0.18B)($0.24B)($0.27B)($0.26B)($0.14B)
EBITDA Margin %(computed)-79.62%-407.84%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Myovant Sciences Ltd.

关于Myovant Sciences Ltd.(MYOV)损益表

Myovant Sciences Ltd.(MYOV)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,MYOV实现营收$0.23B,毛利润$0.18B(毛利率77.68%),净利润($0.21B)(净利率-89.18%)。

常见问题

MYOV · 4 问

Myovant Sciences Ltd.(MYOV)2022财年营收为$0.23B,同比up289.4%。

MYOV revenueMYOV salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08